Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: CVD

2021 ESC Guidelines on Cardiovascular Disease Prevention

Presented By
Prof. Frank Visseren, Guidelines Task Force Chair
Conference
ESC 2021

26 October, 2021 11:52

AHA 2020: Polypill + aspirin prevents cardiovascular events

Presented By
Prof. Salim Yusuf , Population Health Research Institute, Hamilton, Canada
Trial
TIPS-3
Journal
Physician’s Weekly
Conference
AHA Scientific Sessions 2020

15 April, 2021 16:38

AHA2020: Inclisiran effective across age and genders for hyperlipidemia

Presented By
Dr. Kausik “Kosh” Ray, Imperial College London, UK
Trial
Phase 3, ORION-11
Journal
Physician’s Weekly
Conference
AHA 2020

15 April, 2021 16:23

No age cap for lipid-lowering therapy

Presented By
Prof. Børge Nordestgaard, University of Copenhagen, Denmark
Journal
Physician’s Weekly
Conference
AHA Scientific Sessions 2020

15 April, 2021 15:28

Finerenone lowers CV events in diabetic CKD patients

Presented By
Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece
Trial
Phase 3, FIDELIO-DKD
Conference
AHA 2020

18 February, 2021 11:33

Intensive blood pressure lowering benefits older adults

Presented By
Prof. William Cushman, University of Tennessee Health Science, USA
Trial
SPRINT
Conference
AHA 2020

18 February, 2021 11:13

Dapagliflozin reduces renal risk independent of CV disease status

Presented By
Prof. John McMurray, University of Glasgow, Scotland
Trial
DAPA-CKD
Conference
AHA 2020

18 February, 2021 10:18

Clever trial design gets patients back on statins: the SAMSON trial

Presented By
Dr James Howard, Imperial College London, UK
Trial
SAMSON
Conference
AHA 2020

17 February, 2021 15:10

Polypill plus aspirin reduces cardiovascular events

Presented By
Prof. Salim Yusuf, Population Health Research Institute, Canada
Trial
TIPS-3
Conference
AHA 2020

17 February, 2021 14:58

Lowering LDL cholesterol in older patients is beneficial

Presented By
Dr Baris Gencer, Brigham and Women’s Hospital, USA
Conference
AHA 2020

17 February, 2021 14:54

No CV benefit from omega 3 in high-risk patients

Presented By
Prof. Michael Lincoff, Cleveland Clinic, USA
Trial
STRENGTH
Conference
AHA 2020

17 February, 2021 14:44

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By
Prof. R. Scott Wright, Mayo Clinic, USA
Trial
Phase 3, ORION
Conference
AHA 2020

17 February, 2021 14:37

Remote risk management programme effective and efficient

Presented By
Prof. Benjamin Scirica, Brigham and Women’s Hospital, USA
Conference
AHA 2020

17 February, 2021 14:31

Healthy lifestyle lowers mortality irrespective of medication burden

Presented By
Dr Neil Kelly, Weill Cornell University, USA
Trial
REGARDS
Conference
AHA 2020

17 February, 2021 14:24

Fewer CV complications than expected in AHA COVID-19 Registry

Presented By
Prof. James de Lemos, University of Texas Southwestern Medical Center, USA
Trial
AHA COVID-19 CVD Registry
Conference
AHA 2020

17 February, 2021 13:39

Effects of CVD in hospitalised COVID-19 patients

Presented By
Prof. Ann Marie Navar, University of Texas Southwestern, USA
Conference
AHA 2020

17 February, 2021 13:22

High-dose influenza vaccine in patients with CVD

Presented By
Prof. Orly Vardeny, University of Minnesota Medical School, USA
Trial
Phase 4, INVESTED
Conference
AHA 2020

17 February, 2021 10:36

2020 Sports Cardiology and Exercise in Cardiovascular Patients Guidelines

Presented By
Prof. Antonio Pelliccia, Institute of Sports Medicine and Science, Italy
Conference
ESC 2020

5 November, 2020 13:53

2020 Adult Congenital Heart Disease Guidelines

Presented By
Prof. Helmut Baumgartner, University Hospital MĂĽnster, Germany
Conference
ESC 2020

5 November, 2020 13:46

SGLT2 inhibitor improves cardiovascular outcomes in heart failure patients

Presented By
Dr Milton Packer, Baylor University Medical Center, USA
Trial
Phase 3, EMPEROR-Reduced trial
Conference
ESC 2020

5 November, 2020 13:40

Reduced cardiovascular outcomes with early rhythm control

Presented By
Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany
Trial
EAST-AFNET 4
Conference
ESC 2020

5 November, 2020 13:35

DAPA-CKD: Dapagliflozin improves CKD survival ± diabetes

Presented By
Prof. Hiddo Heerspink, University of Groningen, the Netherlands
Trial
DAPA-CKD trial
Conference
ESC 2020

5 November, 2020 13:23

Low-dose colchicine reduces CV death and ischaemic events in coronary disease

Presented By
Dr Stefan Nidorf, Heart Care Western Australia, Australia
Trial
LoDoCo2 trial
Conference
ESC 2020

5 November, 2020 13:19

Antihypertensives also reduce CV risk in people with normal blood pressure

Presented By
Prof. Kazem Rahimi, University of Oxford, UK
Trial
BPLTTC study
Conference
ESC 2020

5 November, 2020 13:14

Restrictive blood transfusion non-inferior and cost-effective strategy

Presented By
Prof. Philippe Gabriel Steg, University of Paris, Frane
Trial
REALITY trial
Conference
ESC 2020

5 November, 2020 13:05

Rivaroxaban protects limbs and ischaemic events in CAD-PAD patients

Presented By
Prof. William Hiatt, University of Colorado, USA
Trial
VOYAGER PAD trial
Conference
ESC 2020

5 November, 2020 12:57

Antisense APOC3 oligonucleotide lowers triglyceride and atherogenic lipoproteins

Presented By
Prof. Jean-Claude Tardif, University of Montréal, Canada
Trial
Phase 2, AKCEA-APOCIII-LRx study
Conference
ESC 2020

5 November, 2020 12:54

Reduced progression of coronary atherosclerosis with icosapent ethyl

Presented By
Prof. Matthew Budoff, Harbor-UCLA Medical Center, USA
Trial
EVAPORATE trial
Conference
ESC 2020

5 November, 2020 12:48

SGLT2 inhibitor ertugliflozin shows similar mortality but fewer HF hospitalisations

Presented By
Prof. Francesco Cosentino, Karolinska University Hospital, Sweden
Trial
VERTIS CV
Conference
ESC 2020

5 November, 2020 12:39

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By
Prof. Yutao Guo , Chinese PLA General Hospital, China
Conference
ESC 2020

5 November, 2020 12:27

The Yale COVID-19 Cardiovascular Registry

Presented By
Dr Manan Pareek, Yale University School of Medicine, USA
Trial
Yale COVID-19 Cardiovascular Registry
Conference
ESC 2020

5 November, 2020 12:24
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy